Arcus Biosciences, Inc.
RCUS· NYSE
Released Nov 8, 2018, after the close
10-Q filed Nov 8, 2018, 39 days after period end · 0001564590-18-028583
| Metric | Q3 2018 | Q3 2017 |
|---|---|---|
| Revenue | $4.29M | $163.00K |
| Net Income | -$10.81M | -$23.12M |
| EPS Diluted | -$0.25 | -$11.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2018 · filed Nov 8, 2018 · 39 d after period end
+1.4% from the close of Nov 8, 2018 to the close of Nov 12, 2018, the first after the release.